Characteristics such as age, PSA doubling time, tumor volume, and presence of late genitourinary or gastrointestinal radiation toxicity should be taken into account when selecting eligible patients for focal salvage treatment and for ruling out patients who will not benefit from local treatment. Here, KLK3 is linked to neoplasm.